COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,432 Articles (22,835 medRxiv, 8,597 bioRxiv)

Most recent first Previous |  Page 1336: Articles 13351-13360  | Next

The potential impact of delta variant of SARS-CoV-2 in the context of limited vaccination coverage and increasing social mixing in Bogota, Colombia
Espana, G., Cucunuba, Z. M., Cuervo-Rojas, J., Diaz, H., Gonzalez-Mayorga, M., Ramirez, J. D.
10.1101/2021.08.06.21261734 — Posted: 2021-08-07
Prevalence and effect of bacterial co-infections on clinical outcomes in hospitalized COVID-19 patients at a tertiary care centre of India
Pathak, A., Singh, S., Singh, S., Patel, S. S., Fatima, N., Garg, A., Ghoshal, U., Sahu, C.
10.1101/2021.08.06.21261695 — Posted: 2021-08-07
Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime
Kant, R., Dwivedi, G., Zaman, K., Sahay, R. R., Sapkal, G., Kaushal, H., Nyayanit, D., Yadav, P., Deshpande, G., Singh, R., Chowdhary, S., Gupta, N., Kumar, S., Abraham, P., Panda, S., Bhargava, B.
10.1101/2021.08.06.21261716 — Posted: 2021-08-07 Discussion: Onsite
Epidemiological characteristics of the B.1.526 SARS-CoV-2 variant
Yang, W., Greene, S., Peterson, E. R., Li, W., Mathes, R., Graf, L., Lall, R., Hughes, S., Wang, J., Fine, A.
10.1101/2021.08.04.21261596 — Posted: 2021-08-07 Discussion: Onsite
Recording of 'COVID-19 vaccine declined' among vaccination priority groups: a cohort study on 57.9 million NHS patients' primary care records in situ using OpenSAFELY
Curtis, H. J., Inglesby, P., MacKenna, B., Croker, R., Hulme, W. J., Rentsch, C. T., Bhaskaran, K., Walker, A. J., Morton, C. E., Evans, D., Mehrkar, A., Bacon, S. C., Bates, C., Hickman, G., Ward, T., Morley, J., Cockburn, J., Davy, S., Schultze, A., Williamson, E. J., McDonald, H. I., Tomlinson, L., Mathur, R., Eggo, R. M., Wing, K., Wong, A. Y., Forbes, H., Tazare, J., Parry, J., Hester, F., Harper, S., O'Hanlon, S., Eavis, A., Jarvis, R., Avramov, D., Griffiths, P., Fowles, A., Parkes, N., Evans, S. J., Douglas, I. J., Smeeth, L., Goldacre, B.
10.1101/2021.08.05.21259863 — Posted: 2021-08-07
Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey
Sahanic, S., Tymoszuk, P., Ausserhofer, D., Rass, V., Pizzini, A., Nordmeyer, G., Hüfner, K., Kurz, K., Weber, P. M., Sonnweber, T., Boehm, A., Aichner, M., Cima, K., Boeckle, B., Holzner, B., Rumpold, G., Puelacher, C., Kiechl, S., Huber, A., Wiedermann, C. J., Sperner-Unterweger, B., Tancevski, I., Bellmann-Weiler, R., Bachler, H., Piccoliori, G., Helbok, R., Weiss, G., Loeffler-Ragg, J.
10.1101/2021.08.05.21261677 — Posted: 2021-08-07
Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study
Perez Gonzalez, A., Araujo-Ameijeiras, A., Fernandez-Villar, A., Crespo, M., Poveda, E.
10.1101/2021.08.05.21261634 — Posted: 2021-08-07
Megakaryocytes are a Novel SARS-CoV-2 Infection Target and Risk Factor for Mortality and Multi-Organ Failure
Patton, M. J., Fortmann, S. D., Frey, B. F., Vieira, C. P., Reddy, S. B., Huls, F., Crouse, A., Floyd, J., Prasad, R., Hanumanthu, V. S., Sterrett, S., Zucker, J. D., Li, P., Erdmann, N., Goepfert, P. A., Gaggar, A., Grant, M. B., Might, M.
10.1101/2021.08.05.21261552 — Posted: 2021-08-07
Distinct age-specific SARS-CoV-2 IgG decay kinetics following natural infection
Sjaarda, C. P., Moslinger, E., Tozer, K., Colautti, R. I., Kheitan, S., Meurant, R., Van Cleaf, S., Ardakani, A., Bosnjak, O., Ghaffari, A., Sheth, P. M.
10.1101/2021.08.05.21259465 — Posted: 2021-08-07
The unique evolutionary dynamics of the SARS-CoV-2 Delta variant
Stern, A., Fleishon, S., Kustin, T., Mandelboim, M., Erster, O., Israel Consortium of SARS-CoV-2 sequencing, , Mendelson, E., Mor, O., Zuckerman, N.
10.1101/2021.08.05.21261642 — Posted: 2021-08-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).